1. A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas. Issue 10 (3rd October 2017) Authors: Sborov, Douglas W.; Canella, Alessandro; Hade, Erinn M.; Mo, Xiaokui; Khountham, Soun; Wang, Jiang; Ni, Wenjun; Poi, Ming; Coss, Christopher; Liu, Zhongfa; Phelps, Mitch A.; Mortazavi, Amir; Andritsos, Leslie; Baiocchi, Robert A.; Christian, Beth A.; Benson, Don M.; Flynn, Joseph; Porcu, Pierluig... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 10(2017) Page Start: 2310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome. Issue 12 (19th September 2020) Authors: Saygin, Caner; Larkin, Karilyn; Blachly, James S.; Orwick, Shelley; Ngankeu, Apollinaire; Gregory, Charles T.; Phelps, Mitch A.; Mani, Shylaja; Walker, Alison; Garzon, Ramiro; Vasu, Sumithira; Walsh, Katherine J.; Bhatnagar, Bhavana; Klisovic, Rebecca B.; Grever, Michael R.; Marcucci, Guido; Byrd... Journal: American journal of hematology Issue: Volume 95:Issue 12(2020:Dec.) Page Start: 1457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Approaches to handling missing or "problematic" pharmacology data: Pharmacokinetics. (5th May 2021) Authors: Irby, Donald J.; Ibrahim, Mustafa E.; Dauki, Anees M.; Badawi, Mohamed A.; Illamola, Sílvia M.; Chen, Mingqing; Wang, Yuhuan; Liu, Xiaoxi; Phelps, Mitch A.; Mould, Diane R. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 4(2021) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. Issue 1 (1st December 2017) Authors: Zhu, Xiaohua; Badawi, Mohamed; Pomeroy, Steven; Sutaria, Dhruvitkumar S.; Xie, Zhiliang; Baek, Alice; Jiang, Jinmai; Elgamal, Ola A.; Mo, Xiaokui; La Perle, Krista; Chalmers, Jeffrey; Schmittgen, Thomas D.; Phelps, Mitch A. Journal: Journal of extracellular vesicles Issue: Volume 6:Issue 1(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DNA Origami Nanostructures Elicit Dose‐Dependent Immunogenicity and Are Nontoxic up to High Doses In Vivo. Issue 26 (28th May 2022) Authors: Lucas, Christopher R.; Halley, Patrick D.; Chowdury, Amjad A.; Harrington, Bonnie K.; Beaver, Larry; Lapalombella, Rosa; Johnson, Amy J.; Hertlein, Erin K.; Phelps, Mitch A.; Byrd, John C.; Castro, Carlos E. Journal: Small Issue: Volume 18:Issue 26(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non‐Hodgkin's lymphoma. Issue 1 (30th September 2013) Authors: Jones, Jeffrey A.; Rupert, Amy S.; Poi, Ming; Phelps, Mitch A.; Andritsos, Leslie; Baiocchi, Robert; Benson, Don M.; Blum, Kristie A.; Christian, Beth; Flynn, Joseph; Penza, Sam; Porcu, Pierluigi; Grever, Michael R.; Byrd, John C. Journal: American journal of hematology Issue: Volume 89:Issue 1(2014:Jan.) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. G-CSF improves safety when you start the day after autologous transplant in multiple myeloma. Issue 12 (2nd December 2017) Authors: Sborov, Douglas W.; Cho, Yu Kyoung; Cottini, Francesca; Hade, Erinn M.; Lamprecht, Misty; Tackett, Karen; Sharma, Nidhi; Williams, Nita; Li, Junan; Devine, Steven; Poi, Ming; Phelps, Mitch A.; Hofmeister, Craig C. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 12(2017) Page Start: 2947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. In vitro immunotoxicity assessment of culture-derived extracellular vesicles in human monocytes. (2nd September 2016) Authors: Rosas, Lucia E.; Elgamal, Ola A.; Mo, Xiaokui; Phelps, Mitch A.; Schmittgen, Thomas D.; Papenfuss, Tracey L. Journal: Journal of immunotoxicology Issue: Volume 13:Number 5(2016) Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Letter to the Editor: Exposure–response or clearance–response relationship in immune checkpoint therapy?—A comment on 'correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer' by Basak et al. (June 2019) Authors: Badawi, Mohamed; Coss, Christopher C.; Phelps, Mitch A. Journal: European journal of cancer Issue: Volume 114(2019) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery. Issue 1 (1st December 2017) Authors: Sutaria, Dhruvitkumar S.; Jiang, Jinmai; Elgamal, Ola A.; Pomeroy, Steven M.; Badawi, Mohamed; Zhu, Xiaohua; Pavlovicz, Ryan; Azevedo-Pouly, Ana Clara P.; Chalmers, Jeffrey; Li, Chenglong; Phelps, Mitch A.; Schmittgen, Thomas D. Journal: Journal of extracellular vesicles Issue: Volume 6:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗